Cargando…
MicroRNA-based signatures impacting clinical course and biology of ovarian cancer: a miRNOmics study
BACKGROUND: In Western countries, ovarian cancer (OC) still represents the leading cause of gynecological cancer-related deaths, despite the remarkable gains in therapeutical options. Novel biomarkers of early diagnosis, prognosis definition and prediction of treatment outcomes are of pivotal import...
Autores principales: | Krasniqi, E., Sacconi, A., Marinelli, D., Pizzuti, L., Mazzotta, M., Sergi, D., Capomolla, E., Donzelli, S., Carosi, M., Bagnato, A., Gamucci, T., Tomao, S., Natoli, C., Marchetti, P., Grassadonia, A., Tinari, N., De Tursi, M., Vizza, E., Ciliberto, G., Landi, L., Cappuzzo, F., Barba, M., Blandino, G., Vici, P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8276429/ https://www.ncbi.nlm.nih.gov/pubmed/34256855 http://dx.doi.org/10.1186/s40364-021-00289-6 |
Ejemplares similares
-
Computational miRNomics – Integrative Approaches
por: Hofestädt, Ralf, et al.
Publicado: (2017) -
Pan-Genome miRNomics in Brachypodium
por: Muslu, Tugdem, et al.
Publicado: (2021) -
Neoadjuvant Immune-Checkpoint Blockade in Triple-Negative Breast Cancer: Current Evidence and Literature-Based Meta-Analysis of Randomized Trials
por: Marinelli, Daniele, et al.
Publicado: (2020) -
Eribulin in Triple Negative Metastatic Breast Cancer: Critic Interpretation of Current Evidence and Projection for Future Scenarios
por: Pizzuti, Laura, et al.
Publicado: (2019) -
Immunotherapy in HER2-positive breast cancer: state of the art and future perspectives
por: Krasniqi, E., et al.
Publicado: (2019)